Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TLR3 absence confers increased survival with improved macrophage activity against pneumonia
Madathilparambil V. Suresh, Vladislav A. Dolgachev, Boya Zhang, Sanjay Balijepalli, Samantha Swamy, Jashitha Mooliyil, Georgia Kralovich, Bivin Thomas, David Machado-Aranda, Monita Karmakar, Sanjeev Lalwani, Arulselvi Subramanian, Arun Anantharam, Bethany B. Moore, Krishnan Raghavendran
Madathilparambil V. Suresh, Vladislav A. Dolgachev, Boya Zhang, Sanjay Balijepalli, Samantha Swamy, Jashitha Mooliyil, Georgia Kralovich, Bivin Thomas, David Machado-Aranda, Monita Karmakar, Sanjeev Lalwani, Arulselvi Subramanian, Arun Anantharam, Bethany B. Moore, Krishnan Raghavendran
View: Text | PDF
Research Article Infectious disease

TLR3 absence confers increased survival with improved macrophage activity against pneumonia

  • Text
  • PDF
Abstract

Toll-like receptor 3 (TLR3) is a pathogen recognition molecule associated with viral infection with double-stranded RNA (dsRNA) as its ligand. We evaluated the role of TLR3 in bacterial pneumonia using Klebsiella pneumoniae (KP). WT and TLR3–/– mice were subjected to a lethal model of KP. Alveolar macrophage polarization, bactericidal activity, and phagocytic capacity were compared. RNA-sequencing was performed on alveolar macrophages from the WT and TLR3–/– mice. Adoptive transfers of alveolar macrophages from TLR3–/– mice to WT mice with KP were evaluated for survival. Expression of TLR3 in postmortem human lung samples from patients who died from gram-negative pneumonia and pathological grading of pneumonitis was determined. Mortality was significantly lower in TLR3–/–, and survival improved in WT mice following antibody neutralization of TLR3 and with TLR3/dsRNA complex inhibitor. Alveolar macrophages from TLR3–/– mice demonstrated increased bactericidal and phagocytic capacity. RNA-sequencing showed an increased production of chemokines in TLR3–/– mice. Adoptive transfer of alveolar macrophages from the TLR3–/– mice restored the survival in WT mice. Human lung samples demonstrated a good correlation between the grade of pneumonitis and TLR3 expression. These data represent a paradigm shift in understanding the mechanistic role of TLR3 in bacterial pneumonia.

Authors

Madathilparambil V. Suresh, Vladislav A. Dolgachev, Boya Zhang, Sanjay Balijepalli, Samantha Swamy, Jashitha Mooliyil, Georgia Kralovich, Bivin Thomas, David Machado-Aranda, Monita Karmakar, Sanjeev Lalwani, Arulselvi Subramanian, Arun Anantharam, Bethany B. Moore, Krishnan Raghavendran

×

Figure 7

TLR3–/– mice alveolar macrophages show enriched phagocytic and bactericidal activity: phagocytosis.

Options: View larger image (or click on image) Download as PowerPoint

TLR3–/– mice alveolar macrophages show enriched phagocytic and bacteric...
(A) Alveolar macrophages from WT and TLR3–/– uninjured and injured (KP-infected) mice were treated with FITC-labeled KP. Using a phagocytic assay (serum-opsonized and nonopsonized), relative phagocytic activity was measured (n = 6 per group). (B) Single-cell imaging of alveolar macrophages isolated in the presence and absence of KP infection that were treated with FITC-labeled dead KP with WT and TLR3–/– mice (n = 3 per group). (C) Macrophages were harvested from WT and TLR3–/– mice at 24 hours following live KP administration and subjected to immunofluorescence staining with anti–Klebsiella pneumonia antibody (n = 3 per group). (D) MTT bacterial viability assay: The bactericidal activity in isolated alveolar macrophages from both naive and KP administered mice was assessed (with serum and non–serum opsonized) (n = 4 per group). (E) The Klebsiella hemolysin gene (Khe) expression in real-time PCR: Lung RNA was isolated from WT and TLR3–/– mice following pneumonia, and Khe gene expression was measured (n = 6 per group from 2 separate experiments) Statistical analysis was performed at each time point. Samples were analyzed using 2-tailed unpaired t test with Welch’s correction (*P < 0.05**P < 0.01; ***P < 0.001, ****P < 0.0001 WT vs. TLR3–/– mice). The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts